Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gilliam LK et al. - The advent of commercially available real-time (rt) continuous glucose monitoring (CGM) is revolutionizing diabetes care. This technology, which allows patients to view an approximation of their blood glucose (BG) levels every 5min, permits fine-tuning of a patient's glycemic control that is not possible with self-monitoring of BG. Every clinician who prescribes these devices needs to understand the balance between the potential for improving diabetes control, the safety features, the economic implications, and the patient factors, all of which impact the decision to prescribe rt-CGM for an individual patient.

Today in Diabetes...keeping you current

Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes
Pediatrics, 12/10/09

Sudden death in type 1 diabetes: The mystery of the ‘dead in bed’ syndrome
International Journal of Cardiology, 12/10/09

Prediction of postpartum diabetes in women with gestational diabetes mellitus
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/10/09

Today in Diagnostics...keeping you current

Does Normal Thyroid Gland by Ultrasonography match with Normal Serum Thyroid Hormones and Negative Thyroid Antibodies
Experimental and Clinical Endocrinology & Diabetes, 12/10/09

False Positive test Results for Pheochromocytoma from 2000 to 2008
Experimental and Clinical Endocrinology & Diabetes, 12/10/09

No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address